(HealthDay News) – Use of intermediate-acting non-depolarizing neuromuscular blocking agents during general anesthesia is associated with an increase in the risk of postoperative respiratory ...

Baudax Bio, Inc. BXRX announced additional positive data from its phase II study of BX1000, which is used as a neuromuscular blockade (“NMB”) in patients undergoing elective surgery. The efficacy of ...

On Medindia find the complete list of Neuromuscular Blocking Agents drugs with their available forms and strength. More information is available on each drug including their price list. We recommend ...

MALVERN, Pa., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today ...

Nearly half of drug-caused deaths by health care workers involved drugs that were obtained from their place of work, new research finds. Patients receiving neuromuscular blocking medications as part ...

Eclat Pharmaceuticals announced that it has ended shortages of Bloxiverz (neostigmine methylsulfate) injection for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) ...

An ED physician ordered a neuromuscular blocking agent to sedate a combative patient. However, a nurse administered the drug too soon, before the patient could be intubated. The patient arrested and ...

Neuromuscular blocking agents are frequently administered to pigs used for research. In humans, administration of the drugs is not without risk and may result in accidental awareness under general ...